ClinConnect ClinConnect Logo
Search / Trial NCT05848570

Keeping it LITE: Exploring HIV Risk in Vulnerable Youth With Limited Interaction and Digital Health Intervention

Launched by HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · Apr 27, 2023

Trial Information

Current as of November 01, 2025

Recruiting

Keywords

ClinConnect Summary

The clinical trial titled "Keeping it LITE" is exploring the risk of HIV in young people who identify as sexual and gender minorities (SGM). This study is particularly important because even with improvements in HIV testing and prevention, infection rates among these vulnerable groups are still rising in the United States. By enrolling up to 6,000 participants aged 13 to 34, the trial aims to understand how sexual behaviors and social factors contribute to HIV risk. Participants will use a digital health platform to track their behaviors and receive support over time, which will help researchers identify effective ways to prevent HIV in this population.

To be eligible for the study, young adults aged 18-34 must self-identify as SGM and have had certain sexual experiences in the last six months, such as having unprotected sex or being with someone known to be HIV-positive. Adolescents aged 13-17 who have engaged in any sexual activity may also participate. Throughout the trial, participants can expect to share their experiences and behaviors related to sexual health while receiving support and education about HIV prevention. This study aims not only to gather important information but also to develop better strategies to address the growing HIV epidemic among young SGM individuals.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * For young adults ages 18-34: self-identified SGM young adults ages 18-34 who meet at least one of the following criteria:
  • 1) condomless anal or vaginal intercourse (CAI) with a cisgender man in the last 6 months OR
  • 2) sex with cisgender men and bacterial STI in the last 6 months OR
  • 3) anal or vaginal sex with a known HIV-infected partner in the last 6 months.
  • For adolescents 13-17: self-identified SGM adolescents ages 13-17 who have engaged in any sexual activity (e.g., oral, anal or vaginal sex)
  • Exclusion Criteria:
  • under age 13
  • over age 34

About Hektoen Institute For Medical Research

The Hektoen Institute for Medical Research is a leading nonprofit organization dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a commitment to fostering collaboration among scientists, clinicians, and community stakeholders, the Institute focuses on a wide range of health-related studies, including clinical trials that explore novel therapies and interventions. By leveraging cutting-edge methodologies and a robust network of experts, the Hektoen Institute aims to translate research findings into practical solutions that address pressing health challenges and enhance the quality of life for diverse populations.

Locations

Chicago, Illinois, United States

Patients applied

LH

1 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported